To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults
Phase 1
Not yet recruiting
- Conditions
- Dyslipidemia
- Interventions
- Drug: AJU-C714Drug: C714R
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06933459
- Locations
- 🇰🇷
H+ Yangji Hospital, Seoul, Republic of South Korea, Seoul, Korea, Republic of
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults
Phase 1
Recruiting
- Conditions
- Hypercholesterolemia
- Interventions
- Drug: AJU-C711Drug: C711R
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06931327
- Locations
- 🇰🇷
Bumin Hospital, Seoul, Republic of South Korea, Seoul, Korea, Republic of
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Phase 3
Recruiting
- Conditions
- Essential Hypertension
- Interventions
- Drug: AJU-C52L, AJU-C52Drug: C52R1L, C52R1M
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 190
- Registration Number
- NCT06416865
- Locations
- 🇰🇷
AJU Pharm Co., Ltd., Seoul, Korea, Republic of
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Phase 4
Recruiting
- Conditions
- Chronic ProstatitisChronic Pelvic Pain SyndromeChronic Prostatitis With Chronic Pelvic Pain Syndrome
- Interventions
- Drug: OM-89 [Uro-Vaxom® Capsule]Drug: OM-89 Placebo [Uro-Vaxom® Capsule Placebo]
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 332
- Registration Number
- NCT06345014
- Locations
- 🇰🇷
AJU Pharm Co., Ltd., Seoul, Korea, Republic of
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
Phase 2
Completed
- Conditions
- Dry Eye Syndromes
- Interventions
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT06337981
- Locations
- 🇰🇷
AJU Pharm Co., Ltd., Seoul, Korea, Republic of
Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients
Phase 3
Completed
- Conditions
- Type2 Diabetes
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 235
- Registration Number
- NCT06329674
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
Phase 3
Recruiting
- Conditions
- Dry Eye Syndromes
- Interventions
- Drug: Placebo Group(Vehicle)
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 396
- Registration Number
- NCT06291194
- Locations
- 🇰🇷
AJU Pharm Co., Ltd., Seoul, Korea, Republic of
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05077462
- Locations
- 🇰🇷
H+ Yangji Hospital, Seoul, Republic Of South Korea, Korea, Republic of
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05077475
- Locations
- 🇰🇷
H+ Yangji Hospital, Seoul, Republic Of South Korea, Korea, Republic of
Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: AJU-A51 Tab.Drug: A51R1 Tab. and A51R2 Tab.
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04972539
- Locations
- 🇰🇷
Jang Hee Hong, Daejeon, Korea, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath